Fujian Aonong Biological Technology Group Incorporation Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 4,155.18 million compared to CNY 3,894.03 million a year ago. Revenue was CNY 4,155.18 million compared to CNY 3,894.03 million a year ago. Net loss was CNY 351.68 million compared to net income of CNY 162.02 million a year ago. Basic loss per share from continuing operations was CNY 0.54 compared to basic earnings per share from continuing operations of CNY 0.25 a year ago.